LIVE WEBINAR
Tuesday, November 18th | 11am ET
Duration: 1 hour
Can't make the live date? Register and we'll send you a link to the recording. ​

In biopharma, data volatility is an ongoing challenge, disrupting the real-world data (RWD) pipelines that drive critical insights needed to bring therapies to market. Causes for these data disruptions range from cyber threats and evolving regulations to supply chain disruptions and legacy systems, with consequences that reverberate across teams and impact decision-making and commercial strategy.

A recent McKesson Compile survey found that 68% of senior biopharma professionals in commercial roles experienced claims data volatility in the past year, leading to false insights, delayed decisions, and reassessment of data sourcing and management. With 99% expressing concern about future disruptions, proactive strategies are essential. Join industry experts as they explore:

• The impact of disruptions to the healthcare claim data landscape for biopharma companies
• Which claims are most vulnerable and why diversity in data sources matter
• How to identify and address data disruptions in your analyses to minimize their impact
• The benefits of proactive data management and strategy to bolster resilience

SPEAKERS

Olivia vonNieda
​Vice President and General Manager
McKesson Compile
 

Monica Tabrizi
Senior Sales Engineer
McKesson Compile